Carl Borrebaeck
301 – 310 of 322
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 1995
-
Mark
Generation of diversity in a human anti-viral response
(
- Contribution to journal › Article
-
Mark
A point mutation in a murine immunoglobulin V-region strongly influences the antibody yield in Escherichia coli
(
- Contribution to journal › Article
- 1994
-
Mark
Restricted variable region gene usage and possible rheumatoid factor relationship among human monoclonal antibodies specific for the AD-1 epitope on cytomegalovirus glycoprotein B
(
- Contribution to journal › Article
-
Mark
Site-directed primary in vitro immunization : Production of HIV-1 neutralizing human monoclonal antibodies from lymphocytes obtained from seronegative donors
(
- Contribution to journal › Article
-
Mark
Intra- and extracellular expression of an scFv antibody fragment in E. coli : Effect of bacterial strains and pathway engineering using GroES/L chaperonins
(
- Contribution to journal › Article
-
Mark
Flow cytometric analysis of the stability of antibody production by human × human × mouse heterohybridoma subclones
(
- Contribution to journal › Article
- 1993
-
Mark
Does endogenous glycosylation prevent the use of mouse monoclonal antibodies as cancer therapeutics?
(
- Contribution to journal › Article
-
Mark
Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies
(
- Contribution to journal › Article
-
Mark
Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines
(
- Contribution to journal › Article
- 1992
-
Mark
Epstein-Barr virus-induced transformation of human B lymphocytes : the effect of l-leucyl-l-leucine methyl ester on inhibitory T cell populations
(
- Contribution to journal › Article